Ambrx Biopharma (AMAM) Institutional Ownership → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free AMAM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial MediaStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipSocial Media Institutional Ownership Changes (13F Filings) for Ambrx Biopharma (NYSE:AMAM)CurrentInstitutional OwnershipPercentage77.28%Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$133.01MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$75.66M Get AMAM Insider Trade Alerts Want to know when executives and insiders are buying or selling Ambrx Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AMAM Institutional Buying and Selling by Quarter Ad InvestorPlaceYour Portfolio’s Shield Against Inflation: Gold’s Surge and AI BreakthroughsWhile gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk. As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires. And it's all thanks to Musk's latest AI creation.Click to watch this device in action Ambrx Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/26/2024Virtu Financial LLC20,386$290K0.0%N/A0.032% 2/26/2024Perceptive Advisors LLC78,811$1.12M0.0%N/A0.125% 2/22/2024 Sierra Summit Advisors LLC37,237$530K0.2%N/A0.059% 2/15/2024Old Well Partners LLC14,400$205K0.2%N/A0.023% 2/15/2024Parkman Healthcare Partners LLC87,678$1.25M0.2%-41.5%0.139% 2/14/2024Altitude Crest Partners Inc.43,100$614K0.4%N/A0.068% Get the Latest News and Ratings for AMAM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ambrx Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/14/2024Lighthouse Investment Partners LLC88,925$1.27M0.1%N/A0.141% 2/13/2024Tower Research Capital LLC TRC5,614$80K0.0%+2,288.9%0.009% 2/12/2024Monashee Investment Management LLC207,500$2.96M0.5%+196.4%0.329% 2/12/2024 TD Asset Management Inc140,256$2.00M0.0%+27.0%0.222% 2/6/2024 WuXi AppTec Co. Ltd.1,000,000$14.24M36.9%N/A1.584% 1/31/2024Federated Hermes Inc.330,949$4.71M0.0%-86.2%0.524% 1/30/2024 HealthInvest Partners AB57,847$824K0.7%N/A0.092% 1/24/2024 China Universal Asset Management Co. Ltd.7,303$104K0.0%N/A0.012% 11/15/2023Alps Advisors Inc.45,531$524K0.0%+12.2%0.073% 11/14/2023Monashee Investment Management LLC70,000$805K0.3%N/A0.113% 11/13/2023Federated Hermes Inc.2,395,867$27.55M0.1%N/A3.864% 11/13/2023NWI Management LP160,935$1.85M0.1%N/A0.260% 11/13/2023FMR LLC1,761,058$20.25M0.0%-20.3%2.840% 11/9/2023Innovis Asset Management LLC31,137$358K0.1%+85.1%0.050% 10/27/2023 TD Asset Management Inc110,456$1.27M0.0%+73.3%0.178% 10/24/2023 Bank of New York Mellon Corp47,433$545K0.0%N/A0.076% 8/15/2023Silverarc Capital Management LLC100,000$1.65M0.5%N/A0.162% 8/15/2023HighVista Strategies LLC153,431$2.53M1.2%N/A0.248% 8/15/2023Commodore Capital LP3,175,000$52.26M5.9%-33.9%5.142% 8/14/2023Cormorant Asset Management LP9,616,155$158.28M8.9%+13.1%15.573% 8/11/2023VR Adviser LLC2,484,960$40.90M6.5%-24.7%4.499% 8/11/2023ExodusPoint Capital Management LP477,558$7.86M0.1%+2,349.4%0.865% 8/9/2023 TD Asset Management Inc63,728$1.05M0.0%+358.5%0.115% 8/3/2023Innovis Asset Management LLC16,826$277K0.1%N/A0.030% 7/20/2023 Exchange Traded Concepts LLC9,830$162K0.0%N/A0.018% 7/13/2023QP Wealth Management LLC12,670$209K0.3%N/A0.023% 5/15/2023Commodore Capital LP4,803,447$42.85M6.5%N/A12.433% 5/15/2023Ghost Tree Capital LLC250,000$2.23M0.7%N/A0.647% 5/15/2023Farallon Capital Management LLC361,000$3.22M0.0%N/A0.934% 5/10/2023 Tocqueville Asset Management L.P.12,500$112K0.0%N/A0.032% 5/9/2023Tower Research Capital LLC TRC20,440$182K0.0%+681,233.3%0.053% 4/28/2023Fosun International Ltd249,190$2.22M0.2%-87.1%0.645% 3/15/2023B. Riley Wealth Advisors Inc.20,000$45K0.0%N/A0.052% 2/14/2023Alpine Global Management LLC46,723$106K0.0%N/A0.121% Have you heard of the $11 AI Coin? (Ad)A new set of AI startups are rising... Except you won't find them on the stock market.Find out more about this $11 AI Coin right now11/14/2022Cormorant Asset Management LP2,336,389$2.52M0.2%-6.0%6.050% 5/16/2022Suvretta Capital Management LLC1,491,832$6.15M0.2%+41.0%3.866% 2/15/2022Adage Capital Partners GP L.L.C.1,923,700$17.37M0.0%+5.3%5.107% 2/14/2022Suvretta Capital Management LLC1,057,735$9.55M0.2%N/A2.808% 11/15/2021Tudor Investment Corp Et Al20,143$272K0.0%-66.4%0.053% 11/12/2021Ghisallo Capital Management LLC15,000$203K0.0%-62.5%0.040% 11/9/2021BlackRock Inc.820,221$11.07M0.0%-3.6%2.177% 8/25/2021Marshall Wace North America L.P.32,648$640K0.0%N/A0.087% 8/17/2021Millennium Management LLC144,092$2.82M0.0%N/A0.383% 8/17/2021Octagon Capital Advisors LP450,000$8.82M1.8%N/A1.195% 8/17/2021Boothbay Fund Management LLC13,422$263K0.0%N/A0.036% 8/17/2021 Caas Capital Management LP40,000$784K0.0%N/A0.106% 8/16/2021Tudor Investment Corp Et Al60,000$1.18M0.0%N/A0.159% 8/13/2021FMR LLC3,766,940$68.73M0.0%N/A10.000% 8/12/2021Fosun International Ltd1,932,591$37.88M2.2%N/A5.130% 8/12/2021Monashee Investment Management LLC110,000$2.16M0.3%N/A0.292% 8/11/2021BlackRock Inc.850,676$16.67M0.0%N/A2.258% 7/30/2021Alliancebernstein L.P.70,000$1.37M0.0%N/A0.186% (Data available from 1/1/2016 forward) AMAM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AMAM shares? During the previous two years, 34 institutional investors and hedge funds held shares of Ambrx Biopharma. The most heavily invested institutionals were Cormorant Asset Management LP ($158.28M), Commodore Capital LP ($52.26M), VR Adviser LLC ($40.90M), FMR LLC ($20.25M), WuXi AppTec Co. Ltd. ($14.24M), ExodusPoint Capital Management LP ($7.86M), and Suvretta Capital Management LLC ($6.15M).Learn more on AMAM's institutional investors. What percentage of Ambrx Biopharma stock is owned by institutional investors? 77.28% of Ambrx Biopharma stock is owned by institutional investors. Learn more on AMAM's institutional investor holdings. Which institutional investors have been buying Ambrx Biopharma stock? Of the 30 institutional investors that purchased Ambrx Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Commodore Capital LP ($4.80M), Federated Hermes Inc. ($2.40M), Cormorant Asset Management LP ($1.12M), WuXi AppTec Co. Ltd. ($1M), ExodusPoint Capital Management LP ($458.06K), Suvretta Capital Management LLC ($434.10K), and Farallon Capital Management LLC ($361K). How much institutional buying is happening at Ambrx Biopharma? Institutional investors have bought a total of 12,125,900 shares in the last 24 months. This purchase volume represents approximately $135.25M in transactions. Which Ambrx Biopharma major shareholders have been selling company stock? The following institutional investors have sold Ambrx Biopharma stock in the last 24 months: Federated Hermes Inc. ($2.06M), Fosun International Ltd ($1.68M), Commodore Capital LP ($1.63M), VR Adviser LLC ($813.62K), FMR LLC ($449.56K), Cormorant Asset Management LP ($150.00K), and Parkman Healthcare Partners LLC ($62.32K). How much institutional selling is happening at Ambrx Biopharma? Institutional investors have sold a total of 6,852,262 shares in the last 24 months. This volume of shares sold represents approximately $90.84M in transactions. Related Companies: BEAM Institutional Ownership TWST Institutional Ownership FUSN Institutional Ownership RXRX Institutional Ownership DNA Institutional Ownership INBX Institutional Ownership SANA Institutional Ownership ADMA Institutional Ownership KYMR Institutional Ownership NMRA Institutional Ownership This page (NYSE:AMAM) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ambrx Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.